Summary. Islet cell antibodies were investigated in 127 nondiabetic children after mumps infection and in four out of seven children who developed diabetes mellitus shortly after active mumps vaccination. Twenty-one of the children who had mumps and all four vaccinated children who were tested had islet cell cytoplasmic antibodies. In contrast, islet cell surface antibodies were detected in 43 out of 68 patients with mumps infection and in 32 out of 44 patients with other viral diseases.
Mumps and other viral infections have repeatedly been linked with the development of diabetes mellitus. Observations of diabetes occurring shortly after mumps infection date back to the last century and continue to recent years [1] [2] [3] [4] .
In 1979, we found islet cell cytoplasmic antibodies (ICA) in the serum of a girl who developed Type 1 diabetes three weeks after mumps infection [5] . This observation prompted us to search further for islet cell antibodies in serum samples of mumps-infected children and to study prospectively their islet cell antibody titre and glucose metabolism. Besides cytoplasmic ICA, islet cell surface antibodies (ICSA) and the HLA-type were determined. In addition, data were collected from 7 children who developed diabetes mellitus after active mumps immunization.
Subjects and methods

Patients
Serum samples from 127 children seen at the children's hospital of the University of Giessen because of mumps complications such as meningoencephalitis and pancreatitis were investigated over the last 5 years. As children with mumps without complications do not usually attend hospital, our patients constitute a selected population. Three children developed diabetes mellitus after mumps vaccination. Data from a further three vaccinated children were kindly provided by Prof. Ehrengut (Medical Director of the Public Health Department, Hamburg, FRG) and of one additional child by Prof. Zuppinger (Children's Hospital, Berne, Switzerland). Sera from these children were analysed for ICA by the indirect immunofluorescence technique. Forty-four serum specimens of patients with viral infections other than mumps and 40 sera from control subjects without known viral infections or disturbed glucose tolerance were investigated in the same way.
MeNo~
Complement-fixing islet cell antibodies (CF-ICA) and non-complement-fixing cytoplasmic islet cell antibodies (ICA) were detected by the indirect immunofluorescence technique on fresh frozen blood group 0 human pancreas as described by Bottazzo and coworkers [6] . ICSA were investigated by the use of suspensions of isolated rat islet ceils after collagenase and trypsin digestion according to Lernmark et al. [7] with slight modifications. As a first step, the sera to be tested were absorbed with rat liver cells as well as spleen cells. Mumps antibodies were determined by the complement fixation test [8] . A significant rise in antibody titre was not obtained in all cases, since the serum samples could not always be drawn at the appropriate time in the course of the disease. HLA-typing was carried out in 45 mumps-infected children from heparinized blood by the lymphocytotoxicity test. For DR-typing, B lymphocytes were prepared using a nylon wool column as described recently [9] .
Results
Out of 127 sera from children with severe mumps infections, 21 were ICA-positive (Fig. 1 ). There was a very high prevalence of ICA in serum samples investigated in 1979 to 1981 and a decrease of the ICA-incidence in subsequent years. In 1979 to 80, 13 out of 26 mumps-infected patients showed ICA. During the following seasons, 7 out of 25 (1980-81), I out of 27 (1981-82) and none out of 49 (1982-83 and 1983-84) were positive (Fig.l) .
These discrepancies were confirmed by retesting sera obtained at different times together on the same source of human pancreas after 2-4years storage at -70 ~ with comparable results (Fig. 2) . Thus technical reasons for these differences could be largely ruled out (r=0.961, Spearman rank test). About 50% (11 out of 21) of the ICA detected in these patients fixed complement. The CF-ICA were almost exclusively of medium or high titre, ranging from ~l : 8 to 1 : ]28 (Fig. ] ). In 44 serum samples of patients suffering from other viral infections such as coxsackie, measles, rubella and adenoviruses, ICA were undetectable. On the other hand, ICSA were found in 42 out of 68 sera from children (62%) with mumps infection and in 32 sera from 44 patients (73%) with other viral diseases. In the control group (n = 40), there was one positive ICA test at 1 : 4 (2.5%) and six positive ICSA tests at 1 : 2 and 1 : 4 (14%) (Fig. 3) . During the observation period (1979-1983), there was no significant yearly variation in the i~ncidence and titre of ICSA in sera from patients studied suffering from viral infections (Fig. 4) . All but one of these patients patients, DR3 and/or DR4 were found in all children who developed diabetes mellitus two to four weeks after mumps vaccination ( Table 2 ). All children of that group were positive for DR4 and, in addition, three for DR3. All of those patients tested were also ICA-positive.
Discussion
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In view of the numerous case reports of diabetes occuring after mumps [10] [11] [12] [13] [14] , it is tempting to speculate about a causal relationship. As there is a high incidence of such virus infections, however, one should consider AAA 000 9 000 00 000 0000 0000 000 000 that the occurence of diabetes after mumps could be fortuitous. It would be desirable that such considerations either are substantiated or disproven by a comparison of the real frequency of such events with a statistical probability of the occurence by chance. To our knowledge, this approach has not been taken. It would involve a prospective study of considerable dimensions. Therefore we found it worthwhile to try what might be called a second-best approach. We tested such patients for ICA, ICSA and determined their HLA-type; we did not specifically look for other antibodies such as rheumatoid factor. Compared with normal subjects, there was no significant difference of HLA-frequencies in the ICA-positive group of mumps-infected patients nor any difference from the ICA-negative group of patients, as suggested previously [9] . The typical HLA-associations as established for Type i diabetes [15] were not seen in ICA-positive mumps patients (Table 1) . Even in patients with both DR3 and DR4, exposure to the mumps virus did not lead to production of ICA in all cases or onset of diabetes mellitus as could be seen in three ICA negative children (Table 1 , cases [15] [16] [17] .
This, together with the negative results reported by other investigators [16] , indicates that some additional predisposing factors are needed for the development of Type 1 diabetes. Our initial finding of a frequency of greater than 50% of ICA in mumps patients [5] has decreased to zero during recent years. There was a high correlation between the concentration of ICA detected and its complement fixation (Fig. 1) . Similar observations were reported recently for Type 1 diabetic patients [17, 181. At present, we cannot explain this, although it may be due to differences between the mumps virus strains circulating in the population at different times, as shown by the use of monoclonal antibodies [19] .
Few children developed diabetes after mumps vaccination and only one child after mumps infection. Taking these single observations together with other anecdotal case reports, it is remarkable that it is usually coxsackie B or mumps infection which is reported in connection with the onset of Type I diabetes [1-3, 20, 21] . The virus infection was usually observed shortly, i.e. a few weeks, before diabetes appeared. Over the past few years, however, evidence has accumulated that a period of many years may be required for the disease to develop [22] . Thus it seems highly unlikely to us that, in the cases reported, the onset of diabetes is primarily due to the recent virus infection or active vaccination. A virus infection, however, could be the final insult to the immune system or islets which are undergoing destructive autoimmune processes leading to the onset of clinical diabetes.
